Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...

According to CEO Srikrishna Ramakarthikeyan, the re-listing of the mid-tier IT company will not change its focus or business ...

Cofounder and CEO Anuj Srivastava will transition to the role of chairman of the board, while Ramakant Sharma, currently the chief operating officer, will take over as CEO.

Diagnostyka SA’s shares surged in the Polish laboratory operator’s Warsaw debut, signaling a solid start for one of Europe’s ...